chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Booster; headache; joint soreness; swollen/painful L armpit lymph node; swollen/painful L armpit lymph node; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 27 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 29Dec2021 16:00 (Lot number: 33B0BA) at the age of 27 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: JUNEL taken for contraception. Vaccination history included: Bnt162b2 (dose number: 1, lot number: EL0142, administration date: 03Jan2021 in Left arm), administration date: 03Jan2021, when the patient was 26 years old, for Covid-19 immunization; Bnt162b2 (dose number: 2, lot number: EL3247, administration date: 20Jan2021 at 08:30 AM  in Left arm), administration date: 20Jan2021, when the patient was 26 years old, for Covid-19 immunization, reaction(s): "Dose 1 on 03Jan2021 and Dose 2 on 20Jan2021". The following information was reported: IMMUNISATION (non-serious) with onset 30Dec2021, outcome "unknown", described as "Booster"; HEADACHE (non-serious) with onset 30Dec2021, outcome "not recovered", described as "headache"; ARTHRALGIA (non-serious) with onset 30Dec2021, outcome "not recovered", described as "joint soreness"; LYMPHADENOPATHY (non-serious), LYMPH NODE PAIN (non-serious) all with onset 30Dec2021, outcome "not recovered" and all described as "swollen/painful L armpit lymph node". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of headache, arthralgia, lymphadenopathy, lymph node pain.  Additional information: On 31Dec2021, patient was tested for covid using nasal swab result of which was negative. Patient had no known allergies. Patient did not receive any other vaccine in four weeks. Patient was not diagnosed with covid in the past.  Follow-up attempts are completed. No further information is expected.
Elevated blood pressure, reaching at times over 200.  Stays in 170-193 range
red upper arm.  swelling /redness/itchy skin, starting from injection site, and slowly moving  down to inner aspect of elbow. accompanied by slight fever.  site of injection is now losing its redness and itchiness.  did apply Benadryl cream twice to relieve the itching.
Temperature of 100.5; she had a reaction; chills; had extreme joint pain; shooting pains on side/body aches; sore throat; headache; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), ARTHRALGIA (had extreme joint pain), PAIN (shooting pains on side/body aches), OROPHARYNGEAL PAIN (sore throat) and HEADACHE (headache) in a 55-year-old female patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) (batch no. ASKU) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 29-Sep-2023, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) .5 milliliter. On 29-Sep-2023, the patient experienced CHILLS (chills), ARTHRALGIA (had extreme joint pain), PAIN (shooting pains on side/body aches), OROPHARYNGEAL PAIN (sore throat) and HEADACHE (headache). On an unknown date, the patient experienced PYREXIA (Temperature of 100.5) and VACCINATION SITE REACTION (she had a reaction). At the time of the report, CHILLS (chills), ARTHRALGIA (had extreme joint pain), PAIN (shooting pains on side/body aches), OROPHARYNGEAL PAIN (sore throat) and HEADACHE (headache) had not resolved and PYREXIA (Temperature of 100.5) and VACCINATION SITE REACTION (she had a reaction) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.5.     The action taken with mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown) was unknown.   For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication not reported.   Treatment medication not reported.  The patient woke up this morning and had chills, had extreme joint pain and shooting pains on side, body aches, chills, sore throat, bad headache and the temperature was 100.5. She stated she called because she had a reaction..   This case was linked to US-MODERNATX, INC.-MOD-2023-743076 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 02-Oct-2023: 02-Oct-2023: Live follow up contains new event.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-743076:Same patient, Bivalent  moderna vaccine
Pt entered vaccination site and stated "I always pass out when I get a shot."  Pt was vaccinated while lying on 3 chairs with father, several nurses, and site-lead present.  Approximately three minutes after injection, Pt stated that he was feeling dizzy, became pale, and lost consciousness for approximately 45 seconds.  Once he regained consciousness, Pt denied any pain or other discomfort.   Pt stated that he would like to remain lying down "for a few minutes; it helps me feel better."  Pt was held in post-vac for a total of 30 minute.  He stated that his symptoms had resolved and left site with father, escorted to vehicle by nurse.
Diagnosed with COVID; Diagnosed with COVID; pain and muscle spasms down her leg; pain and muscle spasms down her leg; prevented her from walking sometimes; lot of pain in her back and neck; lot of pain in her back and neck; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) for a sponsored program.  A 57 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "Rheumatoid arthritis" (ongoing). The patient's concomitant medications were not reported. The following information was reported: COVID-19 (medically significant) with onset 23Aug2021, outcome "unknown", DRUG INEFFECTIVE (medically significant), outcome "unknown" and all described as "Diagnosed with COVID". The patient underwent the following laboratory tests and procedures: grip strength: (unspecified date) had a problem gripping the pfs; (23Aug2021) unknown results; sars-cov-1 test: (23Aug2021) positive, notes: she was diagnosed with COVID. Therapeutic measures were taken as a result of covid-19 which included treatment with a prednisone pack but that did not help her at all. Clinical course: The patient was vaccinated. However, on 23Aug2021, she was diagnosed with COVID. Her symptoms included pain and muscle spasms down her leg that prevented her from walking sometimes.Since getting COVID she had a lot of pain in her back and neck. She was treated She stated she had an appointment in the near future with a pain clinic.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Severe cellulitis left arm (Streptococcal) requiring 3 day hospitalization; Also acute clot in internal jugular vein
No additional AEs reported; reconstituted with expired diluent; This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 16-JUN-2021, the patient was vaccinated with dose of varicella virus vaccine live (oka/merck) (VARIVAX) (lot#S029534, an invalid lot number, expiration date: 20-SEP-2022 (formulation, strength, dose, frequency, route of administration were not reported) reconstituted in expired sterile diluent, 0.5 ml (lot # N026989, expiration date: 13-JUL-2018) (formulation, strength, frequency, route of administration were not reported), both for prophylaxis (expired product administered). No adverse events were reported.
Swollen, red painful injection site. The arm was significantly swollen, indurated and tender. She was running a fever. 03/01/07-records received from PCP and facility for DOS 01/21-02/02/07 DC DX: Cellulitis of left upper arm. Reaction to Pneumovax vaccination Developed significant swelling, redness, warmth, pain and tenderness of left upper arm. Temp 100.8.
This spontaneous report as received from a nurse practitioner refers to multiple patients of unknown age and gender. The nurse practitioner reported, that on an unknown dates, the patients were vaccinated with improperly stored doses of VARIVAX (lot #, expiration date 23-SEP-2017 and lot # L037561, expiration date 23-NOV-2017 (dose and route of administration were not reported). No adverse effects were reported. No product quality complaint (PQC) was reported. Additional information has been requested.
Fingers were tingling; This is a spontaneous report from a contactable pharmacist via Regulatory Authority. A 60-year-old female patient received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- UNKNOWN) via an unspecified route of administration on 26Aug2021 as dose 1, single (at the age of 60-years-old) for COVID-19 immunization. Patient medical history and concomitant medications were not reported. Patient experienced events after receiving the Pfizer-BioNTech Covid19 vaccine, today. After administration, a couple minutes later she said her fingers were tingling on 26Aug2021. He reported that she did leave the pharmacy and he intended to follow-up with her later today. He also noted he did not observe anything out of the ordinary with administration. The outcome of the event was unknown.   The lot number for [BNT162B2], was not provided and will be requested during follow up.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Fever, chills, dizziness, vomiting, extreme menstrual cramps without bleeding, enlarged lymph nodes both armpits with extreme tenderness lasting 2 weeks.
This spontaneous report was received from a physician refers to a patient of unknown age and gender. Medical history and concurrent conditions were not reported. On an unknown date the patient was vaccinated with PNEUMOVAX 23 in the arm (strength, dosage, route and lot# were not reported). Concomitant therapy was not reported. The physician informed that on an unknown date the patient experienced peripheral swelling, reported as swelling in the arm, the outcome of the peripheral swelling was unknown. Additional information is not expected because the reporter refused additional contact.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 07-OCT-2014 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 (STRENGTH: 0.5ml, lot # K004281, expire date 22-MAR-2015; dose and route unknown). The total cumulative excursion time was 1488 hours with the lowest recorded temperature of 20 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Immediate redness, then swelling, raised local area that became hot to touch, by that night I was running fever, had headache, nausea, overall fatigue, body ache, glands in neck seemed swollen... these symptoms lasted for 5 days.  After the 5 days when fever broke, my legs felt weak and started to have spasms that locked my legs into stretched out position. My legs became painful, starting with mostly on the right, but then both.  By the next week I started to lose use of my legs and I ended up in a wheelchair because unable to walk.   It is now in August and I am no longer in a wheelchair and although I am about to walk some, I still have difficulty and must rest a lot or I am unable to take normal steps, the legs still cause a lot of pain, but even that is improving.
PATIENT GOT JANSSEN COVID-19 VACCINE @ 12:58 AND CAME BACK TO THE PHARMACY AT ABOUT 13:50 WITH A COMPLAINTS OF NOT FEELING GOOD . THE STORE ASSOCIATES CALLED 911 AND PATIENT WAS SUPPORTED BEFORE SHE WAS TAKEN TO THE HOSPITAL PATIENT WAS RESPONDING WHEN THE EMS CAME.
Since then she has has aches in her thigh area.; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Since then she has has aches in her thigh area.) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066D211A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Since then she has has aches in her thigh area.). On 02-Aug-2021, PAIN IN EXTREMITY (Since then she has has aches in her thigh area.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient is scheduled for shoulder surgery on 31-Aug and 2nd dose is due 23-Aug-2021.  No concomitant medication was reported.  The treatment information was unknown.
Mild headache began 24 hours after vaccine Nausea began 31 hours after vaccine Vomiting began 32 hours after vaccine (1 episode of vomiting)
Systemic: Headache-Severe, Systemic: Other- Heart palpitations, dry/burning lips, hand tremors-Medium; lasted 1 day
Pt. developed fever of 103 F for 3 days, fever reducing medication bought it down to 101 F, general body aches and malaise.
mom states that on approx 22DEC96 pt going limp;when mom got home from work pt turned blue around the mouth & had red spots on face, chest & arms then disappeared;pt was taken to ER then transferred to another hosp;
malaise; weakness; nausea; This is a spontaneous report from a contactable healthcare professional (patient). A 46-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EJ1685 and expiry date: unknown), via an unspecified route of administration on the left arm, on 19Dec2020 08:00 at a single dose for COVID-19 immunization. The patient medical history was not reported. Patient was not pregnant at time of vaccination. Concomitant medication included linaclotide (LINZESS), omeprazole, ascorbic acid (VIT C), and ergocalciferol (VIT D).  The patient previously took erythromycin and DEMEROL and experienced allergy. The day after first injection, patient had extreme malaise, weekness and nausea on 20Dec2020 06:00. Outcome of the event was recovered. No treatment was received for the events. Patient was not diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination.
onset began 11Jan91, T 101, pain & swelling, general achiness & pain in the shoulder only, nausea/vomiting, delirium 6-9 min /p injection 7 malaise
Body aches, headache, chills, fatigue, nausea.  I had these same reactions to the first shot but this second shot was worse.
Nurse documented that Hepatitis A adult dose was administered when a pediatric/adolescent dose should have been given.
Ear infection; Tired; Her sinuses, she was more congested; Impacted her allergies; Arm was sore at injection site; Headache; Cough; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of SINUS CONGESTION (Her sinuses, she was more congested), EAR INFECTION (Ear infection), COUGH (Cough), HYPERSENSITIVITY (Impacted her allergies) and INJECTION SITE PAIN (Arm was sore at injection site) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Thyroiditis, unspecified, Blood pressure high and Seasonal allergy. Concomitant products included FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]) for an unknown indication.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced COUGH (Cough) and HEADACHE (Headache). On 18-Feb-2021, the patient experienced SINUS CONGESTION (Her sinuses, she was more congested), HYPERSENSITIVITY (Impacted her allergies) and INJECTION SITE PAIN (Arm was sore at injection site). On 19-Feb-2021, the patient experienced FATIGUE (Tired). On 28-Feb-2021, the patient experienced EAR INFECTION (Ear infection). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency. On 20-Feb-2021, INJECTION SITE PAIN (Arm was sore at injection site) and FATIGUE (Tired) had resolved. On 09-Mar-2021, EAR INFECTION (Ear infection) had resolved. On 11-Mar-2021, SINUS CONGESTION (Her sinuses, she was more congested) and HYPERSENSITIVITY (Impacted her allergies) had resolved. At the time of the report, COUGH (Cough) and HEADACHE (Headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Other treatment medications include Flonase and ear drops.
11day p/vax pt devel 101.1f, has varicella over face, neck, back, chest, abd, buttocks, legs. site swelling w/papules
NO ADVERSE EVENTS HAVE BEEN REPORTED SINCE 12/31/2022 COVID VACCINE ADMINISTERED WITHOUT BEING DILUTED 0.7ML INJECTED RIGHT ARM IM. TOTAL OF DOSES IN VIAL EQUIVALENT TO 10 AFTER DILUTION OF 1.3 ML OF SODIUM CHLORIDE
a child accidently received PROQUAD and MMR II; This spontaneous report was received from a registered nurse referring to a 17-month-old patient of unknown gender. The patient's historical condition, concomitant drugs and allergy to drugs were not reported.   On 15-OCT-2020, the patient was accidently vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (0.5 milliliter (ml), strength, route, lot number and expiration date were not reported) and measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) (dose, strength, route, lot number and expiration date were not reported) (accidental overdose) for prophylaxis.
Arm soreness at the injection site that lasted 48 hours; A small, firm, and tender lump on my collar bone on theside of the injection site (1 week later).; This is a spontaneous report from a non-contactable consumer, the patient. A 47-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EW0175) via an unspecified route of administration on 08May2021 at 10:45 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 08May2021 at 12:30, the patient experienced arm soreness at the injection site that lasted 48 hours and on an unknown date in May2021, a small, firm and tender lump on the collar bone on the side of the injection site (1 week later). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events arm soreness at the injection site that lasted 48 hours  was resolved on 10May2021; while that of the small, firm and tender lump on the collar bone on the side of the injection site was unknown at the time of this report.   No follow-up attempts are possible. No further information is expected.
The swelling is under her left arm pit, It hurts a little, and is keeping her up at night; The swelling is under her left arm pit, It hurts a little, and is keeping her up at night; The swelling is under her left arm pit, It hurts a little, and is keeping her up at night; This is a spontaneous report from a Consumer or other non-health care professional (Patient) via a Regulatory Authority. A 62-years-old female patient received bnt162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration in arm left (also reported as left arm) on 26Mar2021 (at the age of vaccination of 62-years-old) as dose 2, single for covid-19 immunization. Patient's relevant medical history and concomitant medications were not reported. Historical vaccine included patient received bnt162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration, on an unspecified date in 2021 as dose 1, single covid-19 immunization, as she did not remember when she got the first vaccine, but she thought it was like 14 days or so before. After patient second COVID vaccine on 26Mar2021 (also reported as Friday). On an unspecified date in Mar2021, patient experienced swelling under left armpit from COVID vaccine She did not know if she noticed under her arm that night or Saturday. She thought it might be a tiny bit worse since she first noticed it. The swelling was under her left arm, and she was given the vaccine in her left arm. It hurt a little and was keeping her up at night. She was always trying to get in a comfortable position, a position where her arm was not down on the swelling. Investigation Assessment was reported as No. Outcome of the events was not recovered.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained. No further information is expected.
December 20th I had a raspy throat, coughing, headache, my temperature was normal, the COVID-19 test was positive. I initially spoke with a nurse at the office and they initially told me it was probably COVID but there was no medication to take. I heard there was an antiviral medication available and  I had a tele-health with a doctor and she prescribed Paxlovid, and I started taking that night. I stayed in the house, and kept my mask on after the initial 5 days. I didn't leave the house until December 29th. On December 30th I stared developing  nasal drainage and sneezing and I retested and was positive again. On January 2nd, I was still testing positive. My temperature is normal and no more runny nose, just a little bit of congestion.
Post Tibial venous blood clot. This is a first time blood clot. Patient went to urgent care because oi tenderness of the calf area. Physician thought it was either cellulitis or blood clot. Blood clot was determined after ultrasound.
rash on face, back & stomach beginning 6AUG97;rash spreads to scalp & extremities 8AUG97 erythematous, sl pink, macular & papular;
woke up only  left shoulder pain weakness going down wrist ,fingers numbness, tingling sensitive to touch, cannot lift my arm above my head , went to  hospital , one day physical therapy then sent home but still cannot lift my left arm. getting MRI soon
During the first few hours following vaccination, I had soreness at the injection sight and a mild headache. About 10hours later, I started to experience more severe symptoms including a fever of 101-102deg, chills/cold sweats, a moderate headache, and body aches. This continued throughout the night and into the next day. In addition, I began to experience a burning sensation in my chest, similar to heart burn. I have consistently been taking Tylenol and recently took Tums to aide with the heartburn feeling.
Developed cellulitis at injection site. Treated with BACTRIM DS 800mg - 160mg tabs BID.
Fever - 12/29/06, bruising at the injection site 12/30/06, swelling approximately golf size at the injection site - 12/30/06.